Truscreen Group Limited (ASX:TRU)

Juliet Hull
Interim CEO
Market Cap (AUD): 23.59M
Sector: Health Care
Last Trade (AUD): 0.06 +0 (+0%)
Tab Bar

1. About

TruScreen Group Limited (ASX:TRU) manufactures and owns all rights to the TruScreen Cervical Cancer Screening System. The system comprises a medical device and Artificial Intelligence- supported (AI) process designed to detect the presence in real time of pre-cancerous and cancerous tissue on the cervix. TruScreen is a patented cervical cancer detection system with distribution agreements in more than 20 countries. The Company’s current key focus is China which accounts for over 50% of sales. Its products have been sold to Vietnam, Russia, Zimbabwe, Mexico, India, Zimbabwe and Saudi Arabia.

TruScreen is a Cervical Cancer Screening Device which offers the latest technology in cervical screening, providing real-time, accurate detection of pre-cancerous and cancerous cervical cells to help improve the health and well-being of women around the world. 

2. Business model

3. Strategy

4. Markets

5. Competition

6. History

7. Team

8. Financials

9. Risk